Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$242.49 - $301.46 $46,315 - $57,578
191 Added 3.91%
5,082 $1.25 Million
Q2 2022

Aug 15, 2022

SELL
$224.73 - $338.64 $67,868 - $102,269
-302 Reduced 5.82%
4,891 $1.21 Million
Q1 2022

May 16, 2022

BUY
$277.25 - $366.29 $33,824 - $44,687
122 Added 2.41%
5,193 $1.72 Million
Q4 2021

Feb 14, 2022

BUY
$300.63 - $371.35 $133,780 - $165,250
445 Added 9.62%
5,071 $1.82 Million
Q3 2021

Nov 10, 2021

BUY
$310.19 - $376.2 $61,727 - $74,863
199 Added 4.5%
4,626 $1.51 Million
Q2 2021

Aug 13, 2021

BUY
$262.71 - $351.17 $22,593 - $30,200
86 Added 1.98%
4,427 $1.38 Million
Q1 2021

May 11, 2021

SELL
$285.92 - $355.13 $27,162 - $33,737
-95 Reduced 2.14%
4,341 $1.38 Million
Q4 2020

Feb 08, 2021

SELL
$251.88 - $324.2 $15,616 - $20,100
-62 Reduced 1.38%
4,436 $1.44 Million
Q3 2020

Oct 20, 2020

BUY
$255.22 - $317.0 $25,522 - $31,700
100 Added 2.27%
4,498 $1.25 Million
Q2 2020

Jul 27, 2020

SELL
$141.4 - $257.09 $7,918 - $14,397
-56 Reduced 1.26%
4,398 $1.06 Million
Q1 2020

May 05, 2020

BUY
$130.51 - $196.01 $11,745 - $17,640
90 Added 2.06%
4,454 $647,000
Q4 2019

Feb 14, 2020

BUY
$159.31 - $223.54 $111,039 - $155,807
697 Added 19.01%
4,364 $744,000
Q3 2019

Nov 14, 2019

BUY
$175.89 - $279.23 $32,539 - $51,657
185 Added 5.31%
3,667 $652,000
Q2 2019

Aug 07, 2019

SELL
$250.96 - $284.94 $752,629 - $854,535
-2,999 Reduced 46.27%
3,482 $907,000
Q1 2019

May 03, 2019

SELL
$276.39 - $362.25 $153,672 - $201,411
-556 Reduced 7.9%
6,481 $1.85 Million
Q4 2018

Feb 06, 2019

SELL
$281.08 - $444.25 $3,372 - $5,331
-12 Reduced 0.17%
7,037 $2.29 Million
Q3 2018

Oct 30, 2018

BUY
$354.53 - $449.75 $33,325 - $42,276
94 Added 1.35%
7,049 $3.17 Million
Q2 2018

Aug 08, 2018

BUY
$278.07 - $446.21 $1.93 Million - $3.1 Million
6,955 New
6,955 $2.85 Million

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Nissay Asset Management Corp Portfolio

Follow Nissay Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nissay Asset Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Nissay Asset Management Corp with notifications on news.